General
Preferred name
FELBAMATE
Synonyms
Felbamate (hydrate) ()
W-554 (hydrate) ()
ADD-03055 (hydrate) ()
ADD-03055 ()
W-554 ()
Felbatol, ADD-03055,W-554 ()
Felbamate hydrate ()
NSC-759866 ()
Felbatol ()
Taloxa ()
Felbamate-d4 ()
P&D ID
PD002715
CAS
25451-15-4
1177501-39-1
106817-52-1
Tags
natural product
drug
available
Approved by
FDA
First approval
1993
Drug Status
approved
withdrawn
Drug indication
Epilepsy
Anti-Epileptic
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION Felbamate is an anticonvulsant. (GtoPdb)
DESCRIPTION Kir6 (KATP) channel opener (Tocris Bioactive Compound Library)
DESCRIPTION NMDA antagonist, acts glycine site (Tocriscreen Plus)
DESCRIPTION Anticonvulsant; glutamate receptor antagonist (LOPAC library)
DESCRIPTION NMDA antagonist, acts glycine site (Tocriscreen Total)
DESCRIPTION The hydrate of Felbamate which is an effective anticonvulsant agent. It was found to be clinically active for probably restraining the effectivity of NMDA. (BOC Sciences Bioactive Compounds)
Compound Sets
32
AdooQ Bioactive Compound Library
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LOPAC library
Mcule NIBR MoA Box Subset
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
Tocriscreen Plus
Tocriscreen Total
Withdrawn 2.0
External IDs
47
Properties
(calculated by RDKit )
Molecular Weight
238.1
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
5
Ring Count
1
Aromatic Ring Count
1
cLogP
0.96
TPSA
104.64
Fraction CSP3
0.27
Chiral centers
0.0
Largest ring
6.0
QED
0.8
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target Type
Ion Channels
Target
iGluR
Glutamate [NMDA] receptor
NMDA Receptor
GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B
NMDAR
Pathway
Membrane Transporter/Ion Channel
Neuronal Signaling
Neuroscience
MOA
Unknown molecular target
Antagonist
GABA(A) Receptor Modulators
glutamate receptor antagonist
Primary Target
NMDA Receptors
Member status
virtual
Indication
epilepsy
ATC
N03AX10
Toxicity type
neurological
Therapeutic Class
Antiepileptic Agents
Solubility
10 mM in DMSO
Source data